Pediatric Oncology
Diagnosis, treatment, and long-term care of cancers in children and adolescents, with age-appropriate, compassionate care.
Dr Revanth M Khandke
Radiation Oncologist, FounderTrained at the Kidwai Memorial Institute of Oncology, Bengaluru. Experienced in modern radiotherapy techniques, treatment planning, and multidisciplinary cancer management, with a clinical approach centered on precision, patient safety, and compassionate, individualized care.
Pediatric Oncology is a specialised branch of oncology dedicated to the diagnosis, treatment, and long-term care of cancers in children and adolescents, from infancy through young adulthood. Childhood cancers are biologically distinct from adult cancers and require specialised, age-appropriate, and compassionate care. The primary goals are to cure cancer, minimise long-term side effects, and ensure normal growth, development, and quality of life.
What cancers are treated
Common childhood cancers include leukemias, lymphomas, brain and spinal cord tumors, neuroblastoma, Wilms tumor (kidney cancer), bone tumors (osteosarcoma, Ewing sarcoma), soft tissue sarcomas, retinoblastoma, and germ cell tumors.
Why pediatric oncology is unique
Childhood cancers often have high cure rates, and long life expectancy makes long-term safety critical. The field requires specialised expertise and infrastructure, and emphasises healing the child, not just treating cancer.
Book your appointment
Speak with Dr. Revanth M Khandke about your case, reports, or treatment options.
Book nowExplore other specialities
View all specialities →Chemotherapy
The backbone of treatment for many childhood cancers.
- Risk-adapted, protocol-based regimens
- Carefully dosed to reduce toxicity
- Delivered with intensive supportive care
Surgery
Used for diagnosis and tumor removal.
- Biopsy and tumor resection
- Organ-sparing techniques whenever possible
Radiation & Targeted Therapy
Used selectively and precisely.
- IMRT and proton therapy
- Strict dose constraints for developing organs
- Monoclonal antibodies, cellular therapies